Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Eskander

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Minerva Ginecologica|May 23, 2014
New paradigms in the surgical and adjuvant treatment of ovarian cancerM Hodeib, R N Eskander, R E Bristow
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2025
Targeting the future: Antibody-Drug Conjugates (ADCs) in platinum-sensitive ovarian cancer in the post-PARP eraL M Chambers, R N Eskander, D M O'Malley
Gynecologic Oncology|October 23, 2021
Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: A Society of Gynecologic Oncology evidenced-based review and recommendationN S Horowitz, R N Eskander, M R Adelman, et al.
Journal of Pediatric and Adolescent Gynecology|May 24, 2011
A retrospective review of the effect of surgeon specialty on the management of 190 benign and malignant pediatric and adolescent adnexal massesR N Eskander, R E Bristow, N C Saenz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group studyK S Tewari, J J Java, R N Eskander, et al.
Gynecologic Oncology|May 21, 2022
Immunotherapy toxicities: An SGO clinical practice statementR E O'Cearbhaill, L Clark, R N Eskander, et al.
European Journal of Cancer Care|January 7, 2017
Independent psychometric validation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)M Stukan, K Zalewski, M Mardas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2024
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancerG Bogani, B J Monk, M A Powell, et al.
ESMO Open|March 19, 2024
Viewing the immune checkpoint VISTA: landscape and outcomes across cancersD Nishizaki, R Kurzrock, H Miyashita, et al.
Gynecologic Oncology|June 14, 2023
Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)B Pothuri, S V Blank, T K Myers, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Minerva Ginecologica|May 23, 2014
New paradigms in the surgical and adjuvant treatment of ovarian cancerM Hodeib, R N Eskander, R E Bristow
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2025
Targeting the future: Antibody-Drug Conjugates (ADCs) in platinum-sensitive ovarian cancer in the post-PARP eraL M Chambers, R N Eskander, D M O'Malley
Gynecologic Oncology|October 23, 2021
Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: A Society of Gynecologic Oncology evidenced-based review and recommendationN S Horowitz, R N Eskander, M R Adelman, et al.
Journal of Pediatric and Adolescent Gynecology|May 24, 2011
A retrospective review of the effect of surgeon specialty on the management of 190 benign and malignant pediatric and adolescent adnexal massesR N Eskander, R E Bristow, N C Saenz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group studyK S Tewari, J J Java, R N Eskander, et al.
Gynecologic Oncology|May 21, 2022
Immunotherapy toxicities: An SGO clinical practice statementR E O'Cearbhaill, L Clark, R N Eskander, et al.
European Journal of Cancer Care|January 7, 2017
Independent psychometric validation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)M Stukan, K Zalewski, M Mardas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2024
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancerG Bogani, B J Monk, M A Powell, et al.
ESMO Open|March 19, 2024
Viewing the immune checkpoint VISTA: landscape and outcomes across cancersD Nishizaki, R Kurzrock, H Miyashita, et al.
Gynecologic Oncology|June 14, 2023
Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)B Pothuri, S V Blank, T K Myers, et al.
Pageof 2